| Dr Catherine Vickroy Pierce, MD | |
|
7101 Jahnke Rd, Richmond, VA 23225-4017 | |
| (804) 323-8820 | |
| Not Available |
| Full Name | Dr Catherine Vickroy Pierce |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 7101 Jahnke Rd, Richmond, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144220351 | NPI | - | NPPES |
| 006603939 | Medicaid | VA | |
| 31246 | Other | OPTIMAHEALTH | |
| 220025113 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101051671 (Virginia) | Primary |
| Entity Name | Commonwealth Laboratory Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942200555 PECOS PAC ID: 3870503139 Enrollment ID: O20060501000689 |
News Archive
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
Many men survive prostate cancer, but thousands of others - whose cancer spreads - inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.
The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
Celsis International is pleased to announce that the United States Patent and Trademark Office today issued U.S. Patent No. 7,604,929 to Celsis In Vitro Technologies (Celsis IVT). This patent generally covers processes by which the company creates its unique LiverPool(TM) products for drug discovery research.
Thomson Reuters, the authority on research analytics and decision support citation data for more than half a century, announced today that it has begun working with thousands of institutions and research facilities to produce a one-of-a-kind resource. This
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Catherine Vickroy Pierce, MD Po Box 5468, Martinsville, VA 24115-5468 Ph: () - | Dr Catherine Vickroy Pierce, MD 7101 Jahnke Rd, Richmond, VA 23225-4017 Ph: (804) 323-8820 |
News Archive
The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.
Many men survive prostate cancer, but thousands of others - whose cancer spreads - inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.
The U.S. Food and Drug Administration has approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.
Celsis International is pleased to announce that the United States Patent and Trademark Office today issued U.S. Patent No. 7,604,929 to Celsis In Vitro Technologies (Celsis IVT). This patent generally covers processes by which the company creates its unique LiverPool(TM) products for drug discovery research.
Thomson Reuters, the authority on research analytics and decision support citation data for more than half a century, announced today that it has begun working with thousands of institutions and research facilities to produce a one-of-a-kind resource. This
› Verified 9 days ago
Dr. Paul Weisz-carrington, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1201 Broad Rock Blvd, 113, Richmond, VA 23249 Phone: 804-794-9396 | |
Dr. Beth Barton Hewitt, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Elaine Lizabeth Flanders, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Jennifer A Daniel-johnson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 219 N 28th St, Richmond, VA 23223 Phone: 206-552-4889 | |
Dr. Harold Paul Dunn, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-281-8100 | |
Dr. Susan D Roseff, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1250 E Marshall Street, Pathology, Richmond, VA 23298 Phone: 804-828-9746 Fax: 804-828-9749 | |
Dr. Jonathan M Ben-ezra, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall Street, Pathology, Richmond, VA 23298 Phone: 804-828-0902 Fax: 804-828-2812 |